The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Antibiotic-Resistant Infection Treatment Costs Have Doubled Since 2002, Now Exceeding $2 Billion Annually
Abstract
Antibiotic-resistant infections are a global health care concern. The Centers for Disease Control and Prevention estimates that 23,000 Americans with these infections die each year. Rising infection rates add to the costs of health care and compromise the quality of medical and surgical procedures provided. Little is known about the national health care costs attributable to treating the infections. Using data from the Medical Expenditure Panel Survey, we estimated the incremental health care costs of treating a resistant infection as well as the total national costs of treating such infections. To our knowledge, this is the first national estimate of the costs for treating the infections. We found that antibiotic resistance added $1,383 to the cost of treating a patient with a bacterial infection. Using our estimate of the number of such infections in 2014, this amounts to a national cost of $2.2 billion annually. The need for innovative new infection prevention programs, antibiotics, and vaccines to prevent and treat antibiotic-resistant infections is an international priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011
Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M., Enns, E. A., File, T. M., Finkelstein, J. A., Gerber, J. S., Hyun, D. Y., Linder, J. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.4151 · Cited by 1,740
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Too much ado about two-part models and transformation?
Buntin, M. B., & Zaslavsky, A. M. (2004) · Journal of Health Economics · doi:10.1016/j.jhealeco.2003.10.005 · Cited by 732
Roberts, R. R., Hota, B., Ahmad, I., Scott II, R. D., Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L. M., Ciavarella, G. G., Supino, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605630 · Cited by 705
Marston, H. D., Dixon, D. M., Knisely, J. M., Palmore, T. N., & Fauci, A. S. (2016) · JAMA · doi:10.1001/jama.2016.11764 · Cited by 638
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
Baggs, J., Fridkin, S. K., Pollack, L. A., Srinivasan, A., & Jernigan, J. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5651 · Cited by 268
Schmitt, S., McQuillen, D. P., Nahass, R., Martinelli, L., Rubin, M., Schwebke, K., Petrak, R., Ritter, J. T., Chansolme, D., Slama, T., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit610 · Cited by 195
Veteran’s affairs hospital discharge databases coded serious bacterial infections accurately
Schneeweiss, S., Robicsek, A., Scranton, R., Zuckerman, D., & Solomon, D. H. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.07.011 · Cited by 178
Currie, C. J., Berni, E. R., Jenkins‐Jones, S., Poole, C., Ouwens, M., Driessen, S., de Voogd, H., Butler, C., & Morgan, C. L. (2014) · BMJ · doi:10.1136/bmj.g5493 · Cited by 119
Goto, M., Schweizer, M. L., Vaughan‐Sarrazin, M., Perencevich, E. N., Livorsi, D. J., Diekema, D. J., Richardson, K. K., Beck, B. F., ALEXANDER, B. K., & Ohl, M. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3958 · Cited by 96
The effect of obesity on antibiotic treatment failure: a historical cohort study
Longo, C., Bartlett, G., MacGibbon, B., Mayo, N. E., Rosenberg, E., Nadeau, L., & Daskalopoulou, S. S. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3461 · Cited by 82
Aliyu, S., Smaldone, A. M., & Larson, E. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.01.022 · Cited by 62
Trends in Hospitalizations with Antibiotic-Resistant Infections: U.S., 1997–2006
Mainous, A. G., Díaz, V. A., Matheson, E. M., Gregorie, S. H., & Hueston, W. J. (2011) · Public Health Reports · doi:10.1177/003335491112600309 · Cited by 48
The Rise of Methicillin-Resistant Staphylococcus aureus in U.S. Correctional Populations
Malcolm, B. L. (2011) · Journal of Correctional Health Care · doi:10.1177/1078345811401363 · Cited by 37
Metsvaht, T., Pisarev, H., Ilmoja, M., Parm, Ü., Maipuu, L., Merila, M., Müürsepp, P., & Lutsar, I. (2009) · BMC Pediatrics · doi:10.1186/1471-2431-9-72 · Cited by 31
Burnham, J. P., Kwon, J. H., Babcock, H. M., Olsen, M. A. A., & Kollef, M. H. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.192 · Cited by 12
Cited by
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response
Bloom, D. E., & Cadarette, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00549 · Cited by 806
Gender equality in science, medicine, and global health: where are we at and why does it matter?
Shannon, G., Jansen, M., Williams, K., Cáceres, C., Motta, A., Odhiambo, A., Eleveld, A., & Mannell, J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33135-0 · Cited by 534
Shrestha, P., Cooper, B. S., Coast, J., Oppong, R., Do Thi Thuy, N., Phodha, T., Celhay, O., Guerin, P. J., Wertheim, H., & Lubell, Y. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-018-0384-3 · Cited by 288
Metadata
- Authors
- Thorpe, K. E., Joski, P., & Johnston, K. J.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2018-04
- Volume
- 37
- Issue
- 4
- Pages
- 662-669
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2792229834
- Cited by
- 253
- References
- 17
- FWCI
- 18.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.